Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

TNF alpha in skin cells causes weight loss, hair and fat issues, and skin inflammation in mice.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Hair loss is common in IBD patients, and some medications may lower the risk.

HuR is essential for Treg function and preventing autoimmunity.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Hydroxychloroquine is most effective for scarring alopecias, especially when combined with other treatments.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

A woman with undifferentiated connective tissue disease was diagnosed with renal amyloidosis and carpal tunnel syndrome.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Low dose methotrexate does not increase hair fall and may reduce it.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.